reference/30479315

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30479315

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	1425-8153 1689-1392
issueIdentifier	1
pageRange	10-
publicationName	Cellular & Molecular Biology Letters
startingPage	10
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9c0c9745f23d93226351aeebd5c67cc7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_23efa3d058abf07646ee4e5fded9fcf1 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3f1136939be77643f9ea6bd2d54319ff http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ef5c83b678915894472d01713346f3a9 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a8374bec2b5d61065a63fc6af8621e46 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_235bd1fab4a12eab8ee38646c03c685b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_bbf6f1c00ba913254be321bfabc89915 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_dbd3514bd8f8c3807abdaa3d18c8f689
bibliographicCitation	Woźniak M, Konopka CJ, Płoska A, Hedhli J, Siekierzycka A, Banach M, Bartoszewski R, Dobrucki LW, Kalinowski L, Dobrucki IT. Molecularly targeted nanoparticles: an emerging tool for evaluation of expression of the receptor for advanced glycation end products in a murine model of peripheral artery disease. Cellular & Molecular Biology Letters. 2021 Mar 16;26(1):10. doi: 10.1186/s11658-021-00253-0.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7129-2202 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed67321706969085e15b7dc3616bb937 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2864-6757 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e010852ea3bcb443e15126c5ca175670 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_efb4ff2678c94d06c30aa68574f4a5ef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70fd56e4c1291b5934e76e6fd3d55bc9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_adc3cd56b41291160a295df78d86b056 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3dacf7a3345acdb54cf538af76269a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7270-1592 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_955ab1fb56922b63bbfc0834a075d534 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86b73c687ddedc2b5b839cc187b0d7f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63b63fb45a13bb4d4815f12ff33b778a
date	2021-03-16^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC7968326 https://doi.org/10.1186/s11658-021-00253-0 https://pubmed.ncbi.nlm.nih.gov/33726678
isPartOf	https://portal.issn.org/resource/ISSN/1689-1392 https://portal.issn.org/resource/ISSN/1425-8153 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/25486
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Molecularly targeted nanoparticles: an emerging tool for evaluation of expression of the receptor for advanced glycation end products in a murine model of peripheral artery disease
discusses	http://id.nlm.nih.gov/mesh/M000600821
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D058729Q000378 http://id.nlm.nih.gov/mesh/D000067759Q000378 http://id.nlm.nih.gov/mesh/D058729Q000473 http://id.nlm.nih.gov/mesh/D053758Q000737
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D004195 http://id.nlm.nih.gov/mesh/D005453 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D061307Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53358090 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_132851af4cffc895ab2061d8d068eb79 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8817 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_73717aafac1e7701dab0fa02b8936926 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123800 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11310

Showing number of triples: 1 to 59 of 59.